ARIAD to Present at the Jefferies 2016 London Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Jefferies 2016 London Healthcare Conference. Company management will provide an overview of the Company’s business on Wednesday, November 16, 2016 at 4:40 p.m. (GMT).

The ARIAD presentation will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.

About ARIAD

ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts is focused on discovering, developing and commercializing precision therapies for patients with rare cancers. ARIAD is working on new medicines to advance the treatment of rare forms of chronic and acute leukemia, lung cancer and other rare cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).

View source version on businesswire.com: http://www.businesswire.com/news/home/20161102005764/en/

ARIAD Pharmaceuticals, Inc.
For Investors
Jennifer Robinson, 617-503-7298
[email protected]
or
For Media
Liza Heapes, 617-621-2315
[email protected]

Source: ARIAD Pharmaceuticals, Inc.

You May Also Be Interested In

• China Footwear Matchmaking Event Connects Chinese Manufacturers With North American Buyers at MAGIC Las Vegas
• GMO GlobalSign Expands TLS Connect by GMO Availability, Bringing CLM Automation to Small and Medium Enterprises in APAC and the Middle East
• Crypto News: Pepeto Raises $10.66M Fast While Solana Price Prediction Eyes $600